| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.9B | $2.7B | $2.5B | $3.0B | $2.8B | $2.6B | $2.4B |
| Cost of Revenue | $0.9B | $0.9B | $0.9B | $0.8B | $1.1B | $1.0B | $1.0B | $0.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B |
| SG&A Expense | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.6B | $0.4B |
| Operating Income | $1.3B | $1.3B | $1.1B | $1.4B | $1.0B | $1.0B | $0.7B | $0.8B |
| Net Income | $0.9B | $1.0B | $0.6B | $1.0B | $0.7B | $0.7B | $0.4B | $0.6B |
| EPS (Basic) | $6.50 | $6.74 | $4.19 | $6.04 | $4.12 | $4.38 | $2.75 | $3.63 |
| EPS (Diluted) | $6.48 | $6.71 | $4.17 | $6.00 | $4.08 | $4.31 | $2.70 | $3.56 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.2B | $4.3B | $4.4B | $7.0B | $7.8B | $7.6B | $7.1B | $5.9B |
| Current Assets | $2.8B | $0.9B | $0.8B | $0.9B | $0.9B | $0.8B | $0.7B | $0.6B |
| Cash & Equivalents | $2.2B | $0.3B | $0.3B | $0.1B | $0.3B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $5.9B | $4.2B | $4.0B | $5.2B | $5.0B | $4.9B | $4.8B | $3.8B |
| Current Liabilities | $2.3B | $1.2B | $0.8B | $2.3B | $1.8B | $1.4B | $1.5B | $1.3B |
| Stockholders' Equity | $0.3B | $0.1B | $0.3B | $1.7B | $2.8B | $2.7B | $2.3B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | $1.0B | $0.9B |
| Investing Cash Flow | $-0.4B | $-0.1B | $2.7B | $0.3B | $-0.6B | $-0.6B | $-0.9B | $-0.3B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $0.8B | $-1.0B | $-3.8B | $-1.3B | $-0.5B | $-0.4B | $0.0B | $-0.7B |